Yahoo · Sep 15, 2026
Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial Results
Vera Therapeutics takes a step toward securing full Food and Drug Administration approval for its injectable kidney drug, Trutakna.
NYSE · OTSKY
Healthcare · Drug Manufacturers - General
$35.36
Down-$0.64 (-1.76%)
Updated Sep 20, 2026, 3:45 AM
SID Score
6.0/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
OTSKY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning OTSKY.
OTSKY research
Company profile and research snapshot.
OTSUKA HOLDINGS CO ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 15, 2026
Vera Therapeutics takes a step toward securing full Food and Drug Administration approval for its injectable kidney drug, Trutakna.
SeekingAlpha · Aug 6, 2026
2026-08-06. The following slide deck was published by Otsuka Holdings Co., Ltd.
SeekingAlpha · Aug 6, 2026
Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study August 3, 2026 8:01 PM...
SeekingAlpha · Aug 5, 2026
Otsuka Holdings Co., Ltd. (OTSKY) Q2 2026 Earnings Call July 31, 2026 12:30 AM EDTCompany ParticipantsPresentationUnknown ExecutiveI would like to thank...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning OTSKY.